Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus
- PMID: 9311855
- PMCID: PMC192122
- DOI: 10.1128/JVI.71.10.7711-7718.1997
Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus
Abstract
Although live attenuated vaccine strains of simian immunodeficiency virus (SIV) have proven highly effective in protecting macaques against challenge with pathogenic SIV strains, little is known about the mechanisms of protective immunity induced by these vaccines. We examined cytotoxic T-lymphocyte (CTL) responses against SIV in animals infected with SIVmac239delta nef (deficient in nef) or SIVmac239delta 3 (deficient in nef, vpr, and upstream sequences in U3). To enhance detection of SIV-specific CTL activity, we stimulated peripheral blood mononuclear cells with autologous B-lymphoblastoid cell lines which had been infected with recombinant vaccinia viruses expressing SIV proteins and subsequently inactivated with psoralen and UV light. Animals chronically infected with SIV239delta nef or SIV239delta 3 mounted vigorous CTL responses against the SIV Gag and Env proteins. This CTL activity was major histocompatibility class restricted and mediated by CD8+ T lymphocytes. CTL responses persisted at relatively high levels for more than 6 years after infection. Limiting dilution precursor frequency assays demonstrated that the frequency of SIV-specific CTLs was as high as 234 CTL precursors per 100,000 cells. Animals acutely infected with SIV239delta nef developed CTL activity by day 14 after infection, coincident with decreases in viral load. Animals acutely infected with SIV239delta 3 developed CTL responses within 4 weeks of infection. Thus, vaccination of juvenile or adult animals with SIV239delta nef or SIV239delta 3 results in the induction of a vigorous CTL response which arises early in the course of infection and persists for years after a single inoculation of virus.
Similar articles
-
Cytotoxic T lymphocyte response against multiple simian immunodeficiency virusA (SIV) proteins in SIV-infected macaques.J Immunol. 1992 May 1;148(9):2899-908. J Immunol. 1992. PMID: 1349322
-
Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection.J Virol. 2000 Aug;74(16):7485-95. doi: 10.1128/jvi.74.16.7485-7495.2000. J Virol. 2000. PMID: 10906202 Free PMC article.
-
Avipox-based simian immunodeficiency virus (SIV) vaccines elicit a high frequency of SIV-specific CD4+ and CD8+ T-cell responses in vaccinia-experienced SIVmac251-infected macaques.Vaccine. 2004 Jan 26;22(5-6):597-606. doi: 10.1016/j.vaccine.2003.08.028. Vaccine. 2004. PMID: 14741150
-
Cytotoxic T lymphocytes specific for the simian immunodeficiency virus.Immunol Rev. 1999 Aug;170:127-34. doi: 10.1111/j.1600-065x.1999.tb01334.x. Immunol Rev. 1999. PMID: 10566147 Review.
-
Mechanisms of protection against simian immunodeficiency virus infection.Vaccine. 2002 May 6;20(15):1985-7. doi: 10.1016/s0264-410x(02)00083-x. Vaccine. 2002. PMID: 11983259 Review.
Cited by
-
Characterization of CD8+ T cell differentiation following SIVΔnef vaccination by transcription factor expression profiling.PLoS Pathog. 2015 Mar 13;11(3):e1004740. doi: 10.1371/journal.ppat.1004740. eCollection 2015 Mar. PLoS Pathog. 2015. PMID: 25768938 Free PMC article.
-
Immunization with live attenuated simian immunodeficiency virus induces strong type 1 T helper responses and beta-chemokine production.Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14031-6. doi: 10.1073/pnas.96.24.14031. Proc Natl Acad Sci U S A. 1999. PMID: 10570193 Free PMC article.
-
Distinct transcriptome profiles of Gag-specific CD8+ T cells temporally correlated with the protection elicited by SIVΔnef live attenuated vaccine.PLoS One. 2017 Mar 23;12(3):e0173929. doi: 10.1371/journal.pone.0173929. eCollection 2017. PLoS One. 2017. PMID: 28333940 Free PMC article.
-
Pathogenic simian/human immunodeficiency virus SHIV(KU) inoculated into immunized macaques caused infection, but virus burdens progressively declined with time.J Virol. 2000 Nov;74(22):10489-97. doi: 10.1128/jvi.74.22.10489-10497.2000. J Virol. 2000. PMID: 11044093 Free PMC article.
-
Influence of glycosylation on the efficacy of an Env-based vaccine against simian immunodeficiency virus SIVmac239 in a macaque AIDS model.J Virol. 2005 Aug;79(16):10386-96. doi: 10.1128/JVI.79.16.10386-10396.2005. J Virol. 2005. PMID: 16051831 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials